PUBLISHED SAT, FEB 11 202310:00 AM EST Ashley Capoot@ASHLEYCAPOOTSHARE Radioligand therapy, a targeted form of cancer treatment, is only viable for a few days after it’s manufactured. One pharmaceutical company is racing against the clock to deliver it to patients in time. Novartis manufacturing associate checking punches at compressing machine. Source: Novartis In 2010, a...
